Name: EnterNext welcomes Quantum Genomics on Alternext's market in Paris
Uploaded: 2014-04-10T17:44:14+0200
Description: Lionel Segard, CEO of Quantum Genomics, closes the European trading day in Paris. Quantum Genomics specializes in the research and development of drugs used to treat cardiovascular, neurological, and metabolic disorders.

搜索联络表

This page is available in multiple languages

Select Language

Back

10/04/2014

Playing this video will load a content from YouTube, a service of Google LLC. For information on how Google may use your data, see the Google privacy policy.

Accept cookies

Lionel Segard, CEO of Quantum Genomics, closes the European trading day in Paris.

Quantum Genomics specializes in the research and development of drugs used to treat cardiovascular, neurological, and metabolic disorders.